Researchers at the University of Southampton have engineered cells with a ‘built-in genetic circuit’ that produces a molecule that inhibits the ability of tumours to survive and grow in their low oxygen environment.
The genetic circuit produces the machinery necessary for the production of a compound that inhibits a protein which has a significant and critical role in the growth and survival of cancer cells. This results in the cancer cells being unable to survive in the low oxygen, low nutrient tumour micro-environment.
As tumours develop and grow, they rapidly outstrip the supply of oxygen delivered by existing blood vessels. This results in cancer cells needing to adapt to low oxygen environment.
To enable them to survive, adapt and grow in the low-oxygen or ‘hypoxic’ environments, tumours contain increased levels of a protein called Hypoxia-inducible factor 1 (HIF-1). HIF-1 senses reduced oxygen levels and triggers many changes in cellular function, including a changed metabolism and sending signals for the formation of new blood vessels. It is thought that tumours primarily hijack the function of this protein (HIF-1) to survival and grow.
Professor Ali Tavassoli, who led the study with colleague Dr. Ishna Mistry, explains: “In an effort to better understand the role of HIF-1 in cancer, and to demonstrate the potential for inhibiting this protein in cancer therapy, we engineered a human cell line with an additional genetic circuit that produces the HIF-1 inhibiting molecule when placed in a hypoxic environment.
“We’ve been able to show that the engineered cells produce the HIF-1 inhibitor, and this molecule goes on to inhibit HIF-1 function in cells, limiting the ability of these cells to survive and grow in a nutrient-limited environment as expected.
“In a wider sense, we have given these engineered cells the ability to fight back – to stop a key protein from functioning in cancer cells. This opens up the possibility for the production and use of sentinel circuits, which produce other bioactive compounds in response to environmental or cellular changes, to target a range of diseases including cancer.”
The genetic circuit is incorporated onto the chromosome of a human cell line, which encodes the protein machinery required for the production of their cyclic peptide HIF-1 inhibitor. The production of the HIF-1 inhibitor occurs in response to hypoxia in these cells. The research team demonstrated that even when produced directly in cells, this molecule still prevents the HIF-1 signalling and the associated adaptation to hypoxia in these cells.
The next step for the researchers is to demonstrate the viability of this approach to the production and delivery of an anticancer molecule in a whole tumour model system.
Professor Tavassoli adds: “The main application for this work is that it eliminates the need for the synthesis of our inhibitor, so that biologists conducting research into HIF function can easily access our molecule and hopefully discover more about the role of HIF-1 in cancer. This will also let us understand whether inhibiting HIF-1 function alone is enough to block cancer growth in relevant models. Another interesting aspect to the work is that it demonstrates the possibility of adding new machinery to human cells to enable them to make therapeutic agents in response to disease signals.”
The Latest on: Built-in genetic circuit
via Google News
The Latest on: Built-in genetic circuit
- Programming the electron biocomputer with Dopamine redox shuttleson February 12, 2020 at 7:10 am
One need look no further then a diseased basal ganglia—an entire neural ecosystem built in no small part on the ... order features seen in dopaminergic circuits across the evolution of the ...
- Potency Assays for Cell and Gene Therapyon February 1, 2020 at 4:08 am
2 Two-step procedure for developing in vitro potency assays for cell and gene therapy products: 1) Demonstrate that the vector can transfer genetic ... supply chain and built-in redundancy.
- Prince Harry and Meghan Markle's attempt to trademark their Sussex Royal brand is blockedon January 24, 2020 at 12:34 am
a testament to their built-in fan base. It's possible they'll take a cue from the Obamas and start their own production company to pitch their passion projects. It was announced in 2018 ...
- Female chimps with powerful moms are less likely to leave homeon January 20, 2020 at 8:06 am
Yes, being the unwitting target of a brother's misdirected advances might be a pain, but for some, the risk might be offset by the benefits of having a built-in support system. Living close to mom ...
- A Sci-fi Writer’s Predictions of the Futureon January 20, 2020 at 2:13 am
All objects will be printed with circuits, chips, and batteries built-in through a completely new ... The process will allow us to eliminate almost every genetic disease and any natural ...
- Video: Bacteria Transformed Into Living, Blinking Clocks Could Provide Precisely Timed Drug Deliveryon January 19, 2020 at 4:00 pm
In the video above, the bacteria are reading the gene for a fluorescent dye. A genetic circuit with a built-in time delay keeps the blinking at a regular rate, and inter-bacterium communication ...
- Army major Chris Brannigan left Afghanistan fighting the Taliban to care for ill daughteron January 17, 2020 at 8:55 am
It previously said CDLS was a neuro-degenerative condition but this has not been proven. CDLS is a genetic disorder usually caused by a mutation in a developmental gene. An army major left ...
- Aman at 31on June 19, 2019 at 6:40 am
Among the services offered are everything from herbal remedies to genetic analysis to sports ... Nonetheless, 20 of its 31 resorts were built in 2005 or earlier, which brings a challenge to ...
- Understanding the cell cycleon May 1, 2019 at 9:03 pm
To some extent, the operation of these machines is controlled locally; for example, errors of incorporation are corrected by built-in proof reading ... signal transduction circuits because they ...
via Bing News